Bausch Health - Common (VRX) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2025

Type / Class
Equity / Common
Symbol
VRX
Price per share
$6.45
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
171,000
Total reported value
$1,102,950
Share change
0
Number of holders
1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 1 institutional investors reported holding 171,000 shares of Bausch Health - Common (VRX).

Institutional Holders of Bausch Health - Common (VRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 171,000 $1,102,950 $6.45 1
2025 Q2 171,000 $1,138,860 $6.66 1
2025 Q1 171,000 $1,106,370 $6.47 1
2024 Q4 171,000 $1,378,260 -$2,248,740 $8.06 1
2024 Q3 450,000 $3,672,000 -$816,000 $8.16 1
2024 Q2 550,000 $3,833,500 -$655,180 $6.97 1
2024 Q1 644,000 $6,832,840 $0 $10.61 1
2023 Q4 644,000 $5,164,880 -$1,652,120 $8.02 1
2023 Q3 850,000 $6,987,000 -$622,912 $8.22 1
2023 Q2 925,780 $7,415,497 $0 $8.01 1
2023 Q1 925,780 $7,498,818 -$42,282 $8.10 1
2022 Q4 931,000 $5,846,680 $0 $6.28 1
2022 Q3 931,000 $6,414,000 -$3,100,230 $6.89 1
2022 Q2 1,381,000 $11,531,000 -$283,000 $8.35 1
2022 Q1 1,393,386 $31,838,000 -$8,317 $22.85 2
2021 Q4 1,393,750 $38,481,000 $0 $27.61 2
2021 Q3 1,393,750 $38,815,000 -$1,253,223 $27.85 2
2021 Q2 1,438,750 $42,184,000 -$29,320 $29.33 2
2021 Q1 1,439,750 $45,697,000 $0 $31.75 2
2020 Q4 1,439,750 $29,946,000 $0 $20.79 2
2020 Q3 1,439,750 $22,373,000 +$1,010,074 $15.53 2
2020 Q2 1,374,750 $25,143,000 +$914,465 $18.28 2
2020 Q1 1,324,750 $20,534,000 +$2,650,500 $15.51 2
2019 Q4 1,153,750 $34,519,000 +$4,487,910 $29.90 2
2019 Q3 1,003,750 $21,932,000 +$2,075,712 $21.87 2
2019 Q2 908,750 $22,919,000 -$1,891,493 $25.24 2
2019 Q1 983,750 $24,298,000 +$327,281 $24.70 2
2018 Q4 970,500 $17,925,000 +$764,490 $18.47 2
2018 Q3 931,245 $23,770,000 -$3,278,026,115 $25.65 3
2018 Q2 142,025,067 $3,301,746,269 -$136,903,523 $23.24 264
2018 Q1 165,627,430 $2,636,233,991 -$159,225,166 $15.92 297
2017 Q4 173,320,585 $3,605,009,490 +$82,276,723 $20.78 291
2017 Q3 167,435,664 $2,396,130,969 -$60,895,087 $14.33 263
2017 Q2 161,270,693 $2,790,392,084 +$17,352,993 $17.30 288
2017 Q1 170,370,670 $1,879,224,608 -$369,489,895 $11.03 295
2016 Q4 194,105,953 $2,817,682,737 -$702,438,662 $14.52 275
2016 Q3 223,306,879 $5,479,231,767 +$152,461,772 $24.55 324
2016 Q2 219,051,137 $4,412,713,741 -$1,209,767,557 $20.14 312
2016 Q1 262,464,017 $6,912,159,519 -$4,789,002,157 $26.30 351
2015 Q4 297,953,762 $30,347,947,303 -$1,569,022,377 $101.65 429
2015 Q3 297,772,725 $53,091,037,771 +$1,392,076,853 $178.38 524
2015 Q2 287,826,476 $63,941,816,082 +$75,794,681 $222.15 566
2015 Q1 288,566,240 $57,274,378,951 +$1,405,007,332 $198.62 543
2014 Q4 285,154,465 $40,865,311,771 -$1,675,804,187 $143.11 492
2014 Q3 295,272,091 $38,776,374,708 -$715,582,712 $131.20 445
2014 Q2 300,627,022 $37,968,368,960 +$2,429,216,686 $126.12 469
2014 Q1 279,223,377 $36,879,975,782 +$580,104,306 $131.83 442